Autor:	Hyyppä, M. T., Långvik, Vivi -Ann, Rinne, U. K.
Zdroj:	Journal of Neural Transmission; June 1978, Vol. 42 Issue: 2 p151-157, 7p
Abstrakt:	Summary Bromocriptine was used as a treatment for Parkinson's disease in 15 patients for 20 weeks. Immunoreactive plasma lutrophin (LH), follitrophin (FSH), prolactin, and somatotrophin (GH, growth hormone) concentrations were analysed before and during the treatment.
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink